Found 23 matching trials
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer PHASE2 For this study, unfavorable intermediate risk prostate cancer patients will...
Show More Location
NYU Langone Health
Learn More & Join Trial
Safety and Efficacy of IMPT or IMRT for Breast Cancer N/A The purpose of this trial is to compare the toxicities and efficacy of inte...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC PHASE2 This is a randomized Phase II study which is designed to determine the impa...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02) NA To investigate the feasibility and peri-operative complications of preopera...
Show More Location
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer PHASE2 To improve overall survival in patients with metastatic cervical cancer by ...
Show More Status
Active Not Recruiting
Location
UT Southwestern Medical Center
Learn More & Join Trial
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability NA Our objective is based on a personalized approach of adjuvant breast radiot...
Show More Location
Institut Du Cancer de Montpellier
Learn More & Join Trial
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients PHASE2 This is a phase II study to investigate the feasibility of Ultra-hypofracti...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost. NA Phase 1-2 study, comparing ultra-hypofractionnated (UH) to a moderately hyp...
Show More Learn More & Join Trial
Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer NA The aim of this clinical trial is to evaluate the efficacy of adaptive pros...
Show More Location
Centre Eugène Marquis
Learn More & Join Trial